Advertisement
Advertisement
QDEL
QuidelOrtho Corporation Common Stock
10.70
USDSponsored
-2.14
-16.67%
Nov 06, 15:59 UTC -5
Closed
After-Market
10.85
+0.15
+1.41%
QuidelOrtho Corporation Common Stock (QDEL) Earnings
QDEL Earnings Reports
Positive Surprise Ratio
QDEL beat 31 of 43 last estimates.
72%
Next Report
Date of Next Report
Feb 09, 2027
Estimate for Q4 26 (Revenue/ EPS)
$678.90M
/$0.48
Implied change from Q3 26 (Revenue/ EPS)
+9.70%
/+54.84%
Implied change from Q4 25 (Revenue/ EPS)
-6.18%
/+4.35%
QuidelOrtho Corporation Common Stock earnings per share and revenue
On Nov 03, 2026, QDEL reported earnings of 0.31 USD per share (EPS) for Q3 26, beating the estimate of 0.20 USD, resulting in a 50.05% surprise. Revenue reached 618.90 million, compared to an expected 640.70 million, with a -3.40% difference. The market reacted with a +1.85% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.48 USD, with revenue projected to reach 678.90 million USD, implying an increase of 54.84% EPS, and increase of 9.70% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Phibro Animal Health Corporation Class A
Report Date
Nov 04, 2026 For Q1 27
Estimate
$0.81
Actual
$0.79
Surprise
-2.58%
Viemed Healthcare, Inc. Common Shares
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.12
Actual
$0.11
Surprise
-14.00%
Apyx Medical Corporation Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.04
Surprise
+57.98%
Bio-Rad Laboratories, Inc.Class A
Report Date
Nov 04, 2026 For Q3 26
Estimate
$2.24
Actual
$2.65
Surprise
+17.92%
ICU Medical Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
$2.17
Actual
$2.44
Surprise
+11.93%
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.36
Actual
$0.40
Surprise
+10.04%
Prestige Consumer Healthcare Inc.
Report Date
Nov 05, 2026 For Q2 27
Estimate
$1.08
Actual
$1.12
Surprise
+4.28%
Trulieve Cannabis Corp.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.07
Actual
$0.09
Surprise
+26.05%
PERRIGO COMPANY PLC
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.50
Actual
$0.60
Surprise
+18.44%
Nephros Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.02
Actual
$0.05
Surprise
+110.08%
FAQ
What were QuidelOrtho Corporation Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, QuidelOrtho Corporation Common Stock reported EPS of $0.31, beating estimates by 50.05%, and revenue of $618.90M, -3.4% below expectations.
How did the market react to QuidelOrtho Corporation Common Stock's Q3 2026 earnings?
The stock price moved up 1.85%, changed from $14.09 before the earnings release to $14.35 the day after.
When is QuidelOrtho Corporation Common Stock expected to report next?
The next earning report is scheduled for Feb 09, 2027.
What are the forecasts for QuidelOrtho Corporation Common Stock's next earnings report?
Based on --
analysts, QuidelOrtho Corporation Common Stock is expected to report EPS of $0.48 and revenue of $678.90M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.